KAREN WASKOWICZ: Open Payments
NPI 1114449576 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 23 payments from 10 companies in 2025. Trend: 2023 $382 · 2024 $343 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $350 |
| ABBVIE INC. | 4 | $83 |
| PFIZER INC. | 4 | $73 |
| Ferring Pharmaceuticals Inc. | 2 | $40 |
| Procept Biorobotics Corporation | 1 | $36 |
| UROGEN PHARMA, INC. | 1 | $21 |
| Endo USA, Inc. | 1 | $18 |
| Laborie Medical Technologies Corp. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: GEMTESA, BOTOX, XTANDI, ADSTILADRIN, AQUABEAM ROBOTIC SYSTEM, AVEED, Optilume BPH Drug Coated Balloon Catheter, IMFINZI.
Industry payments across UT — which companies pay providers there.
